Device Trial Radar · NCT00667511
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
Last checked: Nov 21, 2026Latest source record: Jan 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- NxStage MedicalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 28, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.
Conditions
- Kidney Failure, Chronic
- End-Stage Renal Disease
Interventions
NxStage System OneDevice
Comparison of Nocturnal (NHD) and Short Daily Hemodialysis (DHD) with the NxStage System One
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy: Compare the Ability to Deliver the Clinically Prescribed Amount of Therapy in the Nocturnal Hemodialysis and Short Daily Hemodialysis Phases.Time frame: Study Week 20
1 more outcomes with a free account
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Satellite Healthcare/Wellbound
San Jose, California
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.